ubmslateOT-logo-ubm

OT mobile menu

Search form

Topics:

News

News

Dr. Roland Seiler presented an analysis of how different bladder cancer molecular subtypes respond to neoadjuvant chemotherapy at the 2017 ASCO Genitourinary Cancer Symposium.

California researchers are now suggesting that analyzing copies of genes may point to new treatments for ovarian cancer as well as for other tumor types. The researchers contend that targetable genetic changes in tumors should not be limited to mutations.

Researchers at Tulane University are reporting on how cancer is able to overcome p53, a key tumor-suppressing protein.

Ahead of the ASCO-sponsored 2017 Genitourinary Cancers Symposium being held February 16th to February 18th in Orlando, Florida, we spoke with Dr. Ana Aparicio about the role of androgen receptors in prostate cancer.

An IHC assay for ALK status in non-small cell lung cancer tumor tissue predicts crizotinib treatment outcomes and offers a rapid and potentially less expensive alternative to older FISH ALK status assays.

Genetic profiling combined with clinical factors may help guide clinicians on how to better manage patients with myelodysplastic syndrome.

Despite significant toxicities, idelalisib improved time to progression for patients with treatment-resistant chronic lymphoblastic leukemia.

Pages

Subscribe to News on [sitename]

By clicking Accept, you agree to become a member of the UBM Medica Community.